Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

Item
http://www.wikidata.org/entity/Q33442189
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.A novel screening system for claudin binder using baculoviral display.Epithelial-mesenchymal transition in ovarian carcinomaEvaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug deliveryEmerging roles of claudins in human cancerThe diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.Redox-sensitive structure and function of the first extracellular loop of the cell-cell contact protein claudin-1: lessons from molecular structure to animals.Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells.[Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
P2860

Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

Item
http://www.wikidata.org/entity/Q33442189
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development and characterizati ...... varian and uterine carcinomas.
@ast
Development and characterizati ...... varian and uterine carcinomas.
@en
type
label
Development and characterizati ...... varian and uterine carcinomas.
@ast
Development and characterizati ...... varian and uterine carcinomas.
@en
prefLabel
Development and characterizati ...... varian and uterine carcinomas.
@ast
Development and characterizati ...... varian and uterine carcinomas.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Development and characterizati ...... varian and uterine carcinomas.
@en
P2093
P2860
P304
P31
P356
10.1016/J.AJOG.2009.02.010
P407
P433
P478
P50
P577
P698
P932